Purpose: Intracranial gliomas are not uncommon in our country. The 
Introduction
Gliomas account for approximately 40% to 67% of primary brain tumors. The incidence rate is approximately 4.0 per 100,000 populations in males and just slight lower in females 1 . Two thirds of all brain tumors are primary neoplasms. Approximately half of all primary brain tumors are glial neoplasm and more than three quarter of all gliomas are astrocytomas. More than three quarters of all astrocytomas are anaplastic astrocytomas and glioblastomamultiforme. Approximately 16500 new cases of primary brain tumors are diagnosed yearly in the USA. Gliomas are the most common of them and comprise 1.35% of all cancers in the USA 2 . The grading of gliomas is required for determining prognosis and directing clinical management 3 .
Two major limitations are associated with histopathologic grading of gliomas: inherent sampling error associated with stereotactic biopsy and inability to evaluate residual tumor tissue after cytoreductive surgery. Malignant gliomas are known to infiltrate the parenchyma following vascular channels of the white matter tracts. This may not be readily appreciated if there is no signal intensity abnormality or enhancement on conventional MR images. Hence, histopathologic grading of gliomas has disadvantages and intrinsic error. The advantage of state-of-the-art MR imaging techniques in evaluating cerebral gliomas is the ability to sample not only the entire lesion, but also the adjacent brain tissue for physiologic and metabolite alterations 4 .
By using primarily morphologic imaging modalities, such as MR imaging, a close correlation has been found between intense gadopentetatedimeglumine enhancement of cerebral astrocytomas and histologic areas of malignant neovascularity and endothelial proliferation. Therefore, contrast enhancement is associated with a higher grade of malignancy 5 .
Histological grading is a means of predicting the biological behaviour of a neoplasm. In the clinical setting, tumor grade is a key factor influencing the choice of therapies, particularly determining the use of adjuvant radiation and specific chemotherapy protocols. The WHO classification of tumors of the nervous system includes a grading scheme that is a malignancy scale ranging across a wide variety of neoplasms rather than a strict histological grading system 6 .
Method & Materials:
It was a cross sectional type of observational study. This study was carried out at Department of Neurosurgery, Dhaka Medical College Hospital (DMCH), Dhaka, Bangladesh during the period of July 2013 to May 2015. Purposive sampling according to availability of the patients and strictly considering the inclusions and exclusions criteria. Only patients having histopathologically proven intracranial gliomas who underwent surgery or stereotactic biopsy were considered as a study population. MRI features that are taken for study are location of tumor, contrast enhancement, peritumoral edema, tumor border definition, mass effect of tumor&Necrosis/cystic changes of tumor.For the validity test sensitivity, specificity, accuracy, positive predictive value and negative predictive value of MRI in detecting the grade of intracranial gliomas were calculated after confirmation of the diagnosis by histopathology. Data was collected from Department of Neurosurgery, Dhaka Medical College Hospital (DMCH), Bangabandhu Sheikh Mujib Medical University (BSMMU), and some private hospitals of Dhaka city.
Results:
This study was conducted on 44 cases of intracranial gliomas at Department of Neurosurgery, Dhaka Medical College Hospital, Dhaka. The purpose of this study was to find the association between MR imaging features and tumor grade of intracranial gliomas. In present study the age of the patients ranged from 4 years to 65years. Mean age was 36.3 years. The highest incidence was in between 31-40 years.
Age incidence in intracranial gliomas is an important variable, which is observed to vary from study to study. In present study, no particular age was found susceptible to develop gliomas. Variation of gliomas with respect to sex is not also uncommon. The present study showed a male predominance (63.6%) at the ratio of 1.75:1 bearing consistency with findings of other investigators 7 .
In this study, out of 44 patients of intracranial gliomas, regarding histopathological subtypes of tumor, 43.2% patients had glioblastoma, 31.8% had diffuse astrocytoma, 9.1% had pilocytic astrocytoma, 6.8% had anaplastic astrocytoma, 6.8% had ependymoma and 2.3% had oligodendroglioma.
In this study regarding histopathological grading, 9.1% was grade I gliomas, 40.9% was grade II gliomas, 6.8% was grade III gliomas and 43.2% were grade IV gliomas. In the present study out of 44 patients, regarding contrast enhancement, 12(27.3%) patients showed no enhancement, 13 (29.5%) patients showed mild to moderate enhancement and 19 (43.2%) patients showed marked enhancement after administration of IV gadolinium contrast. In this study, out of 44 patients of gliomas 28 (63.6%) were males and 16 (36.4%) were females. The male to female ratio was 1.75:1. 
Discussion:
The grading of gliomas is required for determining prognosis and directing clinical management3. Histological grading is a means of predicting the biological behavior of a neoplasm. In the clinical setting, tumor grade is a key factor influencing the choice of therapies, particularly determining the use of adjuvant radiation and specific chemotherapy protocols6
The therapeutic management and prognosis in patients with gliomas depend on the reliable distinction between high and low-grade gliomas. Imaging in patients with brain tumors aims toward the determination of the localization, extend, type, and malignancy of the tumor. Imaging is being used for primary diagnosis, planning of treatment including placement of stereotaxic biopsy, resection, radiation, guided application of experimental therapeutics, and delineation of tumor from functionally important neuronal tissue8. CT and MRI are the mainstays of imaging in current practice. MR imaging with its multiplanar capabilities and superior contrast resolution is now modality of choice9.
The present study showed significant association between the contrast enhancement and WHO grading of gliomas (p=<0.001) bearing consistency with findings of other investigators5,10. There is direct relationship between contrast enhancement and neovascularity present in high grade tumors9. In lowgrade gliomas with little or no alteration of BBB, contrast agent did not enter the extravascular space and no significant contrast enhancement was observed10.
In this study regarding presence of peritumoral edema, in 8(18.2%) patients there is no edema, 20(45.5%) patients showed mild to moderate edema and 16(36.4%) patients showed presence of marked edema. Some investigators demonstrated direct correlation between peritumoral edema with tumor grade (p<0.01)13. Other authorsfound significant association between the perilesional edema and pathological grade of astrocyticgliomas10. Present study also demonstrated significant association (p<0.001) between peritumoral edema and WHO grade of intracranial gliomas.
In present study 54.5% was well circumscribed lesion and 45.5% was poorly circumscribed lesion. Other study10 found significant association between definition of tumor border and the pathological grade of astrocyticgliomas (p<0.02). Our study demonstrated significant association between tumor border definition & WHO grading of gliomas (p=0.001)
In this study 29(65.9%) of patients showed mild to moderate mass effect followed by 12(27.3%) marked mass effect and 3(6.8%) no mass effect. This showed significant association between the mass effect and the WHO grading of gliomas (p=0.003). For gliomasmass effect was the best predictor for assessing tumor grade (p= .0000) using MR imaging3. There is significant association between the mass effect and pathological grade of astrocyticgliomas (p<0.001)10
In this study necrosis or cystic change was absent in 68.2% and present in 31.8%. It is noted that this 31.8% were grade IV lesions. Our study also revealed significant association between necrosis/cystic change of tumor with tumor grade (p=0.001). This was also found in other study3,10
In present study, low grade gliomas characteristically were well defined; displayed no or little mass effect, peritumoral edema; nonenhancing or mild to moderate enhancing lesion on IV contrast administration; and were without necrosis/cystic changes. High gradegliomas were less well defined of poorly defined border; exhibited more mass effect, vesogenic 
Conclusion
The present study revealed that there is significant association between the MR imaging features and histopathological grading of intracranial gliomas. MRI is sensitive, specific and accurate in assessing the grade of gliomas. Contrast enhancement is the most important predictor. Peritumoral edema, tumor border definition, mass effect and necrosis/cystic changes of tumor are also important indicators of tumor grade.
Recommendations
Any patient suspected of having intracranial gliomas should undergo MR imaging with contrast studies to come to a conclusive preoperative diagnosis and to provide better management.
